Infinity I-China announced on January 13 that it has joined with Kleiner Perkins Caufield & Byers China, the China Spring Fund and JAIC in a Series B Financing round of Chiral Quest Corporation. Infinity, a returning investor, has participated in the total $13M round. Chiral Quest, headquartered in New York with operations in Jiashan, China, is a technology-based company creating chiral solutions for the pharmaceutical industry, assisting pharmaceutical and biotechnology companies to develop processes for the manufacture of their candidate drugs.